Location History:
- Denver, CO (US) (2014 - 2016)
- Ann Arbor, MI (US) (2016 - 2018)
Company Filing History:
Years Active: 2014-2018
Title: Adam Stout - Innovator in Pharmaceutical Chemistry
Introduction
Adam Stout is a notable inventor in the field of pharmaceutical chemistry, based in the United States. He has made significant contributions to the development of compounds that have potential therapeutic applications. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Adam Stout holds a patent for "Substituted Quinoline Compounds As S-Nitrosoglutathione Reductase Inhibitors." This invention is directed to quinoline compounds of Formula I, which are useful as S-nitrosoglutathione reductase (GSNOR) inhibitors. The pharmaceutical compositions comprising such compounds offer promising methods for making and using these innovative solutions.
Career Highlights
Throughout his career, Adam has demonstrated a commitment to advancing pharmaceutical research. His work has been instrumental in exploring new avenues for drug development, particularly in the area of GSNOR inhibition. Despite having 10 patents, his contributions to the field are noteworthy.
Collaborations
Adam Stout has collaborated with esteemed colleagues, including Xicheng David Sun and Jian Qiu. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
In summary, Adam Stout is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact health care significantly. His innovative approach to developing S-nitrosoglutathione reductase inhibitors showcases his commitment to advancing medical science.